Alternatively, simpler age-group specific CA125 thresholds, similar to those already use to interpret the prostate specific antigen (PSA) test for prostate cancer in UK primary care [7], could be used in place of the single CA1245 cut-off, to guide clinical decision making. The gene discussed is KLK3; the disease is prostate carcinoma.